CAMBRIDGE, Mass.--(BUSINESS WIRE)--H3 Biomedicine Inc., a biopharmaceutical company specializing in the discovery and development of precision medicines for oncology, is pleased to announce the appointment of Tarek Sahmoud, MD, PhD, as Chief Medical Officer.
